In Vivo Gene Therapy Scientific Animation

In Vivo Gene Therapies in VR

Virtual Reality


REGENXBIO is developing in vivo gene therapies using Adeno-associated viruses (AAV) from their NAV® Technology Platform to treat rare and common diseases.

3D model of RegenxBio conference booth designed by Random42

Using captivating scientific visuals, the animation illustrates the science behind the NAV® Technology Platform, equipping Medical Affairs and Investor Relations teams with vibrant and colorful 3D graphics that make this scientific concept clear and engaging.

Imagery from the animation was used at REGENXBIO’s booth, creating a scientific backdrop that ties in with the visuals and key messages from the animation, resulting in an eye-catching booth that enticed passers-by and helped develop a consistent brand identity.

3D model of gene therapies in virtual reality environment designed by Random42

In addition, our interactive team produced a virtual reality (VR) experience and holographic fan content to be used at industry conferences.

The VR immersed the viewer within the NAV® Technology Platform in an exciting and creative way. A holographic fan was also incorporated into the booth to show animation assets in an eye-catching format.

The assets were used at the 18th Annual WORLDSymposium™ and the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference.

This virtual reality experience has won 6 global industry awards.

Are you interested in seeing how our scientific animation can help you?